Advertisement
Advertisement
U.S. Markets open in 5 hrs 27 mins
Advertisement
Advertisement
Advertisement
Advertisement

GelStat Corporation (GSAC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00240.0000 (0.00%)
At close: 11:01AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0024
Open0.0025
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0024 - 0.0024
52 Week Range0.0010 - 0.0469
Volume31,420
Avg. Volume76,717
Market Cap1.246M
Beta (5Y Monthly)0.85
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    GelStat Provides Corporate Update on Capital Restructuring

    STUART, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC), a development stage company focused on the marketing of over-the-counter and other non-prescription, natural consumer health care products, today provided several updates related to its ongoing capital markets activities and corporate initiatives. As previously announced, the Company is in the process of conducting a Regulation A+, Tier 2, equity financing of up to $5 million (the “

  • GlobeNewswire

    GelStat Announces $5 Million Public Offering Under Regulation A+

    GelStat Corporation Has Been Qualified by the SEC for a Regulation A+ Public OfferingSTUART, Fla., Feb. 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC), a development stage company focused on the marketing of over-the-counter and other non-prescription, natural consumer health care products, announced the launch of a Regulation A+, Tier 2, equity financing of up to $5 million (the “Public Offering”). A copy of the Company's offering circular for the

Advertisement
Advertisement